Gate Neurosciences

Were on a mission to develop a new generation of brain health therapies for the ~1 billion people worldwide suffering from neuropsychiatric and cognitive disorders. Our novel, rapid-acting drug mechanisms address underlying disease biology by enhancing synaptic function, strengthening neuronal connections, and restoring healthy brain signaling. Our approach focuses on precision biomarkers and targeted patient populations, and is rooted in learnings from extensive clinical, preclinical, and translational data across thousands of patients with our molecules. By rethinking whats possible, were creating hope for better mental health treatments and better lives. To learn more about our clinical-stage, next-generation neuroscience pipeline, please...

Gate neurosciences operates in the Biotechnology research industry.

Gate neurosciences's revenue is 11m - 100m

Gate neurosciences has 11 - 50 employees.